{"id":602,"date":"2013-12-16T20:01:37","date_gmt":"2013-12-16T20:01:37","guid":{"rendered":"http:\/\/stg-blogs.bmj.com\/jmg\/?p=602"},"modified":"2013-12-16T20:01:37","modified_gmt":"2013-12-16T20:01:37","slug":"direct-to-consumer-pharmacogenomic-testing-is-associated-with-increased-physician-utilisation","status":"publish","type":"post","link":"https:\/\/stg-blogs.bmj.com\/jmg\/2013\/12\/16\/direct-to-consumer-pharmacogenomic-testing-is-associated-with-increased-physician-utilisation\/","title":{"rendered":"Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation"},"content":{"rendered":"<p>The impact of direct-to-consumer (DTC) pharmacogenomic testing on consumer behavior has not been previously studied.\u00a0 A large sample of adults purchased a DTC pharmacogenomic test and completed baseline and follow-up health behavior assessments.\u00a0 The pharmacogenomic test included testing for drug effectiveness or risk of side effects for 12 medications.\u00a0 At follow-up the 481 individuals who had received their pharmacogenomic results were compared to 844 individuals still awaiting results.\u00a0 Individuals who had received results showed increased physician utilization relative to those awaiting results.\u00a0 Receipt of test results was not associated with any adverse changes in psychological health. (By Cinnamon S. Bloss, Ph.D., <a href=\"http:\/\/jmg.bmj.com\/content\/early\/2013\/12\/16\/jmedgenet-2013-101909\">http:\/\/jmg.bmj.com\/content\/early\/2013\/12\/16\/jmedgenet-2013-101909<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The impact of direct-to-consumer (DTC) pharmacogenomic testing on consumer behavior has not been previously studied.\u00a0 A large sample of adults purchased a DTC pharmacogenomic test and completed baseline and follow-up health behavior assessments.\u00a0 The pharmacogenomic test included testing for drug effectiveness or risk of side effects for 12 medications.\u00a0 At follow-up the 481 individuals who [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/stg-blogs.bmj.com\/jmg\/2013\/12\/16\/direct-to-consumer-pharmacogenomic-testing-is-associated-with-increased-physician-utilisation\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-602","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=602"}],"version-history":[{"count":0,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/602\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stg-blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}